A third jab will be administered to the vulnerable for further protection.
It was reported yesterday that half a million people with weaker immune systems will soon receive a third vaccine shot to increase their Covid protection.
Patients with blood cancer and HIV, for example, may not have had a strong reaction after the first two injections, according to the report.
In the coming weeks, they will be provided an extra dosage of either the Pfizer/BioNTech or Moderna vaccines.
According to the Joint Committee on Vaccination and Immunization, the extra injection will help to “top up” their response.
“We know that those with specific circumstances that make them particularly sensitive to Covid-19 may have had less protection against the virus from two vaccine doses,” stated Health Secretary Sajid Javid.
“I’m determined to do all possible to protect folks in this group, and a third dose will aid in that effort.
“Where clinically appropriate, the NHS will contact clients as soon as possible to discuss their needs and schedule an appointment for a third dose.”
According to a recent study, four out of ten persons with compromised defenses exhibited a lower antibody response after two doses than would be expected.
Patients who are taking medicines that suppress their immune systems, such as recent organ transplant recipients, will be eligible for another shot.
Officials have stated, however, that the extra vaccinations were not part of the UK’s planned booster program.
In June, the JCVI released interim guidance describing plans for a possible booster campaign targeting disadvantaged populations and everyone over the age of 50.
However, despite the NHS’s preparations to begin on Monday, no final decision has been made.
The committee is said to be waiting for more evidence. “Very soon,” a decision on who should receive boosters is expected.
“This is not the start of the booster program,” Mr Javid continued.
“We’re still planning for this to ensure that the vaccine protection people have built up over time and ahead of the winter is maintained. We’ll give priority to individuals who are most vulnerable to Covid.” Between 400,000 and 500,000 patients with compromised immune systems will be identified by family doctors and consultants.
Blood Cancer UK’s chief executive, Gemma Peters, applauded the move, but cautioned that patients should continue to be cautious even after receiving a third dose.
“People with blood cancer are more likely to become extremely unwell as a result of Covid and are less likely to have responded,” she said.